000 | 00637cam a2200217 4500 | ||
---|---|---|---|
001 | S989 | ||
008 | 090401t2001 xxu||||| |||| 00| 0 eng d | ||
082 | _aREFERENCE NAT | ||
110 | _aNational Institute for Clinical Excellence | ||
245 | _aGuidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia | ||
260 |
_aLondon : _bNice, _c2001 |
||
490 | _aTechnology Appraisal Guidance | ||
500 | _aAvailable in print or on-line | ||
500 | _aAvailable in print or on-line | ||
650 | _aGuidelines | ||
942 |
_cBKSTD _n0 |
||
985 | _aGeneral notes | ||
986 | _aGEN | ||
997 | _a0 | ||
999 |
_c93708 _d93708 |